Form 4: Organogenesis CEO Exercises Options, Sells Shares to Cover Taxes

Organogenesis CEO Gary S. Gillheeney exercised stock options and sold shares to cover withholding taxes, while also selling additional shares on the open market.

Summary

• Organogenesis CEO Gary S. Gillheeney exercised 1,067,245 stock options at a price of $0.99 per share on December 5, 2024.
• Following the exercise, Mr. Gillheeney sold 18,416 shares on December 6, 2024, at a weighted average price of $3.65 per share.
• He also sold 41,052 shares on December 9, 2024, at a weighted average price of $3.52 per share.
• These sales were partly to cover withholding taxes related to the option exercise.
• After these transactions, Mr. Gillheeney directly owns 3,359,726 shares of Organogenesis Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of insider transactions, with no indication of positive or negative sentiment. It is a routine filing.

Industry Context

This is a routine filing related to insider transactions, which is common for publicly traded companies. It reflects the CEO's activity in managing his personal holdings of company stock.

Comparison to Industry Standards

• Executive stock option exercises and subsequent sales are a common practice in publicly traded companies, particularly around vesting dates.
• The sale of shares to cover tax obligations is a standard procedure for executives exercising stock options.
• The reported weighted average sale prices are within the typical range for market transactions of this nature.

Stakeholder Impact

• The transactions may have a minor impact on the stock price due to the increased supply of shares in the market.
• Shareholders may view the transactions as a normal part of executive compensation.

Key Dates

Keywords

Organogenesis, stock options, insider trading, SEC Form 4, share sales, CEO, Gary S. Gillheeney